Sichenzia Ross Ference Kesner LLP Represents Alzamend Neuro, Inc. in Qualifying Its Reg A+ Offering Statement

Press Release — New York, NY — December 15, 2016 — Sichenzia Ross Ference Kesner LLP (“SRFK”)  has represented Alzamend Neuro, Inc., a company formed with the intention of preventing, treating and curing Alzheimer’s, in its effort to qualify its Offering Statement on Form 1-A pursuant to Regulation A+.  The Offering Statement was qualified by the Securities & Exchange Commission on December 8, 2016.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Marc Ross and Henry Nisser. Mr. Ross commented that “We found this to be a very interesting project and believe that issuers such as Alzamend Neuro stand to benefit tremendously from the adoption of Reg A+.”  Mr. Nisser stated that “We are very pleased with Alzamend’s success in having its Offering Statement qualified by the SEC and look forward to working with its principals as they move forward with the offering and hopefully subsequent development of a treatment for Alzheimer’s.”

 

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

Visit SRFK's LinkedIn page
Sichenzia Ross Ference Kesner LLP